The Boardroom Recaptured: Why the Delaware Supreme Court’s Reversal in Moelis Resurrects the Stockholder Agreement Playbook

The Sky is No Longer Falling for Corporate Governance

For a brief, terrifying window, the corporate bar thought the bedrock of modern private equity and founder-led governance had collapsed. When the Delaware Court of Chancery issued its initial decision in the Moelis litigation, invalidating a sweeping stockholder agreement that gave founder Ken Moelis veto power over most board decisions, the reaction in law firm drafting rooms was pure panic. Decades of standard-practice governance agreements suddenly looked like unenforceable liabilities.

But predictability has returned to America’s corporate capital. In a monumental January 2026 ruling, the Delaware Supreme Court reversed the Chancery Court’s decision, holding that the stockholder agreement granting broad board-control rights could not be challenged under the theory that it inherently violated Delaware law. For corporate practitioners, this is not just a correction; it is a vital reaffirmation of the state’s commitment to private ordering.

The Section 141(a) Trap

To understand why the Delaware Supreme Court’s intervention is so critical, one must understand the doctrinal trap the Chancery Court had set. Under Delaware General Corporation Law, Del. Code Ann. tit. 8, § 141(a), the "business and affairs of every corporation organized under this chapter shall be managed by or under the direction of a board of directors."

For over half a century, tracing back to cases like Abercrombie v. Davies, 130 A.2d 338 (Del. 1957), Delaware courts have warned against contracts that "sterilize" the board of directors by stripping them of their statutory mandate to exercise independent business judgment. In the Chancery Court’s view, Moelis’s stockholder agreement—which required his pre-approval for a vast array of corporate actions, from issuing dividends to settling litigation—crossed the line from permissible shareholder influence into unlawful board sterilization.

The problem with the Chancery’s rigid, formalistic approach was that it ignored the commercial reality of the modern market. Private equity sponsors, venture capitalists, and visionary founders routinely condition their capital and leadership on these exact types of negative covenants and consent rights. By weaponizing Section 141(a) against a freely negotiated stockholder agreement, the Chancery Court effectively outlawed a foundational tool of corporate finance.

The Supreme Court Restores Private Ordering

The Delaware Supreme Court’s reversal dismantles the Chancery’s theory. By holding that the agreement granting Ken Moelis broad board-control rights could not be challenged on the theory that it violated Delaware law as applied below, the high court has decisively re-centered freedom of contract.

The essential holding for practitioners: A stockholder agreement granting extensive consent and veto rights to a founder or major investor does not, in and of itself, unlawfully usurp the board’s Section 141(a) authority.

The Supreme Court recognized that corporate directors are not "sterilized" simply because the corporation has entered into a binding commercial contract that limits their options. Directors limit their own options every day when they sign debt covenants, exclusive licensing deals, or collective bargaining agreements. A stockholder agreement is fundamentally a contract. Provided it is entered into with proper authority and does not violate the explicit terms of the corporation's charter, it should be respected.

What Changes in Practice Tomorrow?

The immediate practical impact of this reversal cannot be overstated. Here is what changes for the corporate bar:

1. Legacy Agreements are Safe: Following the initial Chancery shockwave, the Delaware legislature rushed to enact statutory overhauls (including the controversial SB 21) to permit certain governance arrangements and shield business leaders. While the Delaware Supreme Court separately upheld that legislative overhaul in February 2026, the statutory fix left a glaring question: what about the thousands of legacy agreements drafted before the new laws took effect? The Supreme Court’s Moelis reversal provides the critical judicial shield for those older contracts, ending the threat of opportunistic plaintiff strike suits aimed at invalidating them.

2. Transactional Drafting Returns to Normal: M&A and capital markets lawyers no longer need to perform unnatural drafting gymnastics to secure sponsor veto rights. While it remains best practice to embed the most critical governance constraints directly into the certificate of incorporation (which has always enjoyed stronger protection under DGCL § 102(b)(1)), practitioners can confidently return to using standard stockholder agreements for negative controls and consent rights.

3. The Death of the Governance Strike Suit: Plaintiffs’ firms that were gearing up to challenge the governance structures of hundreds of newly public, sponsor-backed companies have lost their primary weapon. The Supreme Court has shut the door on the theory that merely possessing these contractual rights is a per se violation of Delaware corporate law.

The Bottom Line

Delaware’s dominance as a corporate haven is built on a delicate balance: enforcing fiduciary duties while maximizing contractual flexibility. The Chancery Court’s original Moelis decision threatened to upend that balance by elevating statutory formalism over commercial reality.

The Delaware Supreme Court’s reversal is a definitive course correction. It signals to Wall Street, Silicon Valley, and corporate boardrooms nationwide that Delaware still understands how modern business actually works. The board may legally manage the corporation under Section 141(a), but the stockholders who provide the capital are fully within their rights to negotiate the boundaries of that management. The stockholder agreement is back.